Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06528236Not Yet Recruiting

Research and Application of Ultrasonic Intelligent Diagnosis System for Ovarian Mass

Role: collaborator

NCT05206799Unknown

The CMCPCTH Research in Chinese Children

Role: collaborator

NCT04965467Withdrawn

Fabry Aim Children Early (ACE) Project

Role: collaborator

All 3 trials loaded